2010Strait Pharmaceutical JournalRequires access

Regulatory effect of pidotimod on Th subsets of children with recurrent respiratory tract infections

Xuyang Chen

Open publisher page 1 citations

Abstract

OBJECTIVE To explore the regulatory effect of pidotimod on Th subsets of children with recurrent respiratory tract infections(RRTIs).METHODS A total of 70 RRTI patients were randomly assigned into the pidotimod group and the control group,for observation of Th1 and Th2 cell subset changes before and after treatment of these patients.RESULTS The Thl/Th2 ratio was comparatively consistent between the two groups before treatment(P0.05);after treatment,the Th1/Th2 ratio was significantly increased in the pidotimod group(P0.01) and insignificantly altered in the control group(P0.05),in comparison to that prior to treatment,and the difference between the two groups was significant(P0.01).The obviously effective rate and total effective rate were evidently higher in the treatment group than the control group(71.4% vs.17.1%,94.3% vs.65.7%;both P0.01).CONCLUSION Pidotimod may ameliorate the cell immune function of RRTI children through regulating the balance of Th1/Th2 cells,so as to elevate the ability of resistance against invasion of exogenous pathogenic microorganisms for children.Due to the accurate,safe and reliable efficacy of pidotimod for treatment of RRTI,it deserves clinical promotion.

About this research paper

What this paper is about

OBJECTIVE To explore the regulatory effect of pidotimod on Th subsets of children with recurrent respiratory tract infections(RRTIs).METHODS A total of 70 RRTI patients were randomly assigned into the pidotimod group and the control group,for observation of Th1 and Th2 cell subset changes before and after treatment of these patients.RESULTS The Thl/Th2 ratio was comparatively consistent between the two groups before treatment(P0.05);after treatment,the Th1/Th2 ratio was significantly increased in the pidotimod group(P0.01) and insignificantly altered in the control group(P0.05),in comparison to that prior to treatment,and the difference between the two groups was significant(P0.01).The obviously effective rate and total effective rate were evidently higher in the treatment group than the control group(71.4% vs.17.1%,94.3% vs.65.7%;both P0.01).CONCLUSION Pidotimod may ameliorate the cell immune function of RRTI children through regulating the balance of Th1/Th2 cells,so as to elevate the ability of resistance against invasion of exogenous pathogenic microorganisms for children.Due to the accurate,safe and reliable efficacy of pidotimod for treatment of RRTI,it deserves clinical promotion.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To explore the regulatory effect of pidotimod on Th subsets of children with recurrent respiratory tract infections(RRTIs).METHODS A total of 70 RRTI patients were randomly assigned into the pidotimod group and the control group,for observation of Th1 and Th2 cell subset changes before and after treatment of these patients.RESULTS The Thl/Th2 ratio was comparatively consistent between the two groups before treatment(P0.05);after treatment,the Th1/Th2 ratio was significantly increased in the pidotimod group(P0.01) and insignificantly altered in the control group(P0.05),in comparison to that prior to treatment,and the difference between the two groups was significant(P0.01).The obviously effective rate and total effective rate were evidently higher in the treatment group than the control group(71.4% vs.17.1%,94.3% vs.65.7%;both P0.01).CONCLUSION Pidotimod may ameliorate the cell immune function of RRTI children through regulating the balance of Th1/Th2 cells,so as to elevate the ability of resistance against invasion of exogenous pathogenic microorganisms for children.Due to the accurate,safe and reliable efficacy of pidotimod for treatment of RRTI,it deserves clinical promotion.

Key concepts: Medicine, Immune system, Internal medicine, Gastroenterology, Respiratory tract, Immunology, Respiratory system

Related papers

Back to paper searchBrowse research topicsOriginal source
Regulatory effect of pidotimod on Th subsets of children with recurrent respiratory tract infections — Research Paper | ScholarLens